- Home
- APLM vs MRM Comparison
APLM vs MRM Comparison
Compare APLM & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- MRM
- Stock Information
- Founded
- APLM 2016
- MRM 2000
- Country
- APLM United States
- MRM Japan
- Employees
- APLM N/A
- MRM N/A
- Industry
- APLM Blank Checks
- MRM Other Consumer Services
- Sector
- APLM Finance
- MRM Consumer Discretionary
- Exchange
- APLM Nasdaq
- MRM Nasdaq
- Market Cap
- APLM 12.3M
- MRM 12.2M
- IPO Year
- APLM N/A
- MRM 2020
- Fundamental
- Price
- APLM $9.56
- MRM $0.99
- Analyst Decision
- APLM Strong Buy
- MRM
- Analyst Count
- APLM 2
- MRM 0
- Target Price
- APLM $425.00
- MRM N/A
- AVG Volume (30 Days)
- APLM 36.2K
- MRM 95.4K
- Earning Date
- APLM 02-15-2025
- MRM 01-01-0001
- Dividend Yield
- APLM N/A
- MRM N/A
- EPS Growth
- APLM N/A
- MRM N/A
- EPS
- APLM N/A
- MRM N/A
- Revenue
- APLM $2,101,000.00
- MRM $44,462,062.00
- Revenue This Year
- APLM N/A
- MRM N/A
- Revenue Next Year
- APLM N/A
- MRM N/A
- P/E Ratio
- APLM N/A
- MRM N/A
- Revenue Growth
- APLM 70.54
- MRM 2.80
- 52 Week Low
- APLM $6.50
- MRM $0.90
- 52 Week High
- APLM $91.00
- MRM $8.39
- Technical
- Relative Strength Index (RSI)
- APLM 46.48
- MRM 33.16
- Support Level
- APLM $9.50
- MRM $0.93
- Resistance Level
- APLM $10.67
- MRM $1.05
- Average True Range (ATR)
- APLM 0.92
- MRM 0.08
- MACD
- APLM -0.04
- MRM 0.06
- Stochastic Oscillator
- APLM 13.17
- MRM 25.53
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.